Literature DB >> 19269522

Barrett's oesophagus.

Nicholas J Shaheen1, Joel E Richter.   

Abstract

Barrett's oesophagus is a metaplastic change of the lining of the oesophagus, such that the normal squamous epithelium is replaced by specialised or intestinalised columnar epithelium. The disorder seems to be a complication of chronic gastro-oesophageal reflux disease, although asymptomatic individuals might also be affected, and it is a risk factor for the development of oesophageal adenocarcinoma, a cancer with rapidly increasing incidence in developed societies. We review the presentation, epidemiology, and risk factors for this condition. We discuss the molecular changes necessary for the development of Barrett's oesophagus and its progression to cancer, and new strides in both the endoscopic detection of the lesion and the treatment of dysplastic disease. Also, we assess the effectiveness of efforts to screen patients at risk of Barrett's oesophagus, and whether such efforts avert cancer death. We conclude with a discussion of future directions for research, focusing on treatment of early neoplasia, and modifications of current practices to show our evolving understanding of this condition.

Entities:  

Mesh:

Year:  2009        PMID: 19269522     DOI: 10.1016/S0140-6736(09)60487-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  106 in total

1.  Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter?

Authors:  Evanthia Zampeli; George Karamanolis; George Morfopoulos; Elias Xirouchakis; Vasiliki Kalampoki; Spyros Michopoulos; Sotiria Savva; Vasilios Tzias; Irene Zouboulis-Vafiadis; Dimitrios Kamberoglou; Spiros D Ladas
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

Review 2.  Angle-resolved low-coherence interferometry: an optical biopsy technique for clinical detection of dysplasia in Barrett's esophagus.

Authors:  Yizheng Zhu; Neil G Terry; Adam Wax
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2012-02       Impact factor: 3.869

3.  Proximal and distal esophageal sensitivity is decreased in patients with Barrett's esophagus.

Authors:  Anne L Krarup; Søren S Olesen; Peter Funch-Jensen; Hans Gregersen; Asbjørn M Drewes
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

4.  Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.

Authors:  Panteleimon Kountourakis; Jaffer A Ajani; Marta Davila; Jeffrey H Lee; Manoop S Bhutani; Julie G Izzo
Journal:  Gastrointest Cancer Res       Date:  2012-03

5.  Detection of dysplasia in Barrett's esophagus with in vivo depth-resolved nuclear morphology measurements.

Authors:  Neil G Terry; Yizheng Zhu; Matthew T Rinehart; William J Brown; Steven C Gebhart; Stephanie Bright; Elizabeth Carretta; Courtney G Ziefle; Masoud Panjehpour; Joseph Galanko; Ryan D Madanick; Evan S Dellon; Dimitri Trembath; Ana Bennett; John R Goldblum; Bergein F Overholt; John T Woosley; Nicholas J Shaheen; Adam Wax
Journal:  Gastroenterology       Date:  2010-09-18       Impact factor: 22.682

6.  Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium.

Authors:  Prateek Sharma; David A Katzka; Neil Gupta; Jaffer Ajani; Navtej Buttar; Amitabh Chak; Douglas Corley; Hashem El-Serag; Gary W Falk; Rebecca Fitzgerald; John Goldblum; Frank Gress; David H Ilson; John M Inadomi; Ernest J Kuipers; John P Lynch; Frank McKeon; David Metz; Pankaj J Pasricha; Oliver Pech; Richard Peek; Jeffrey H Peters; Alessandro Repici; Stefan Seewald; Nicholas J Shaheen; Rhonda F Souza; Stuart J Spechler; Prashanth Vennalaganti; Kenneth Wang
Journal:  Gastroenterology       Date:  2015-08-19       Impact factor: 22.682

7.  Diagnosis and management of Barrett's esophagus for the endoscopist.

Authors:  Sagar S Garud; Steven Keilin; Qiang Cai; Field F Willingham
Journal:  Therap Adv Gastroenterol       Date:  2010-07       Impact factor: 4.409

8.  Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population.

Authors:  Ryu Ishihara; Tsuneo Oyama; Seiichiro Abe; Hiroaki Takahashi; Hiroyuki Ono; Junko Fujisaki; Mitsuru Kaise; Kenichi Goda; Kenro Kawada; Tomoyuki Koike; Manabu Takeuchi; Rie Matsuda; Dai Hirasawa; Masayoshi Yamada; Junichi Kodaira; Masaki Tanaka; Masami Omae; Akira Matsui; Takashi Kanesaka; Akiko Takahashi; Shinichi Hirooka; Masahiro Saito; Yosuke Tsuji; Yuki Maeda; Hiroharu Yamashita; Ichiro Oda; Yasuhiko Tomita; Takashi Matsunaga; Shuji Terai; Soji Ozawa; Tatsuyuki Kawano; Yasuyuki Seto
Journal:  J Gastroenterol       Date:  2016-10-18       Impact factor: 7.527

9.  Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma.

Authors:  DunFa Peng; TianLing Hu; Mohammed Soutto; Abbes Belkhiri; Alexander Zaika; Wael El-Rifai
Journal:  Gut       Date:  2013-04-12       Impact factor: 23.059

Review 10.  MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Takatsugu Kan; Stephen J Meltzer
Journal:  Curr Opin Pharmacol       Date:  2009-09-19       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.